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Summary
A new approach has been developed to detect myocar-
dial cell-hypertrophy, by measuring the intra-cellular
lifetime of water in a mouse model of hypertensive
heart disease, and validating the MRI marker against
measurements of cell dimensions on stained heart slices.
Background
Cardiomyocyte hypertrophy occurs in cardiomyopathies
and in response to pressure overload. However, only
endomyocardial biopsies allow detection, with the inher-
ent risks of invasive catheter-based procedures. Non-
invasive detection of cardiomyocyte hypertrophy using
imaging may detect disease at a subclinical stage and
potentially guide therapy. To-date, no imaging-technique
has been validated to detect hypertrophic response at
the cellular level. We developed a novel measure of cell
size based on the MRI determination of the intra-cellu-
lar lifetime (τic) of water, using pre/post-contrast T1
measurements and a 2-site H-exchange model (2SX-
model). We hypothesized that τic correlates positively
with the histological measure of cardiomyocyte volume
(Vic) in a rodent model of hypertensive heart disease.
Methods
L-NAME (3mg/ml) or placebo were administered
respectively to 17 (bw=37.2±2.3g) and 13 (bw=37.5
±2.5g) male-wild-type mice. Mice were imaged at base-
line and 7-weeks after treatment on a 4.7T-small-animal
MRI-system. T1 (>5T1 measurement/mouse) was quan-
tified with a modified Look-Locker gradient-echo-cine
technique, before and after fractionated Gadolinium-
DPTA administration. Minor (Dmin) and major (Dmaj)
cell-diameters were measured by FITC-labeled wheat
germ-agglutinin staining of cell membranes. Morpho-
metric analysis was performed with a computer-based
system. Vic was calculated from Dmin and Dmaj cell-
diameters using a cylindrical cell-shape approximation.
Results
L-NAME-treated-mice developed hypertrophy (weight-
indexed LVMass 4.1±0.4 for L-NAME vs. 2.2±0.3μg/g
for placebo, p<0.001). Vic (from histology) was substan-
tially higher in L-NAME-treated-animals (19.4*10
3,I Q R
917.1*10
3μmm
3 vs. 10.7*10
3, IQR 9.3*10
3μmm
3;
p<0.0001), while Dmaj/Dmin was smaller (3.4 vs. 4.2,
p<1e-7), compared to controls. τic was significantly
higher in L-NAME-treated animals (0.453±0.10 vs. 0.234
±0.06, p<0.0001). τic increased significantly from base-
line to 7-weeks in animals treated with L-NAME
(p<0.0001) (Figure 1). τic strongly correlated with the
minor cell diameter (r=0756, P<0.001), Vic (r=0.875,
r<0.001) (Figure 1), and more weakly with the major
cell-diameter (r=0.478, p=0.02). τic also correlated with
weight-indexed LVMass (r=0.71, p<0.001). τic demon-
strated an increase from baseline to 7-week (0.177
±0.15), which follows the increase of LVmass (39.43
±36.6μg/g) in the same interval (r=0.69, p<0.001).
Conclusions
Quantification of the intra-cellular lifetime of water (τic)
by MRI provides a robust non-invasive estimation of
cell volume changes, validated here against Vic and
direct morphological measurements. τic correlated more
strongly with Dmin than Dmaj, reflecting the fact that
the dependence τic on Dmax is weak for cylindrical
shapes with Dmax/Dmin~4. Dmin was the shape
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cell-hypertrophy. This novel MRI-based measure of cell
volume may become useful to assess early adverse cellu-
lar remodeling in several cardiac conditions.
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Figure 1 Baseline and 7-week Cell-LifeTIME in control and L-NAME treated-animals. Figure-2: Correlation: intra-cellular volume by histology and
Cell-LifeTIME by MRI.
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